Cargando…
Novel Automated Blood Separations Validate Whole Cell Biomarkers
BACKGROUND: Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied by a dearth of successful whole cell biomarkers for peripheral blood lymphocytes (PBLs). Successful biomarkers could help to track drug effects at early time points in clinical trials to prevent costly...
Autores principales: | Burger, Douglas E., Wang, Limei, Ban, Liqin, Okubo, Yoshiaki, Kühtreiber, Willem M., Leichliter, Ashley K., Faustman, Denise L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142167/ https://www.ncbi.nlm.nih.gov/pubmed/21799852 http://dx.doi.org/10.1371/journal.pone.0022430 |
Ejemplares similares
-
Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
por: Ban, Liqin, et al.
Publicado: (2015) -
Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
por: Faustman, Denise L., et al.
Publicado: (2012) -
THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023) -
Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
por: Okubo, Yoshiaki, et al.
Publicado: (2013) -
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies
por: Dias, Hans F., et al.
Publicado: (2023)